Meiliani MEILIANI, Yori YULIANDRA, Rahman HIDAYAT, Armenia ARMENİA

Blood pressure lowering effect of scopoletin on oxidative stress-associated hypertensive rats

Scopoletin is a coumarin derivative known for its antioxidant capacity. The present study was undertaken to investigate the blood pressure lowering effect of scopoletin in multiple models of hypertensive rats. To obtain animal models of hypertension, a number of 18 Wistar-Kyoto male rats were divided into two groups receiving a combination of oral prednisone and salt for 14 days (PN group, the endocrine hypertension model) while another half received the same inducers with an additional Nω-nitro-L-arginine methyl ester (L-NAME) for 2 days (PNL group, oxidative stressassociated hypertension model). The rats were anesthetized with propofol and subdivided into 3 groups receiving control, scopoletin 10 mg/kg, and tempol 100 µmol/kg. The systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP) and heart rate (HR) were recorded for 120 minutes after a single dose of drug commencement. The serum concentration of nitric oxide (NO) was measured before and at the end of the experiment. The data were analyzed using two-way ANOVA followed by Tukey’s HSD with 95% confidence interval. The results showed that scopoletin decreased the SBP, DBP, and MAP of the rats significantly (p0.1). The concentration of NO in animals receiving scopoletin and tempol was greater as compared control, but there was no significant difference in blood NO between both hypertensive models (p>0.1). The study concludes that scopoletin is effective as blood pressure lowering agent on oxidative stress-associated hypertensive rats.

PDF

___

Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801-812. [CrossRef]
WHO. World Health Organization, Hypertension. World Health Organization. http://www.searo.who.int/topics/hypertension/en/. Published 2017. Accessed September 29, 2017.
Hussain MA, Al Mamun A, Reid C, Huxley RR. Prevalence, awareness, treatment and control of hypertension in Indonesian adults aged ≥40 years: Findings from the Indonesia Family Life Survey (IFLS). PLoS One. 2016;11(8):e0160922. [CrossRef]
Gnonlonfin GJB, Sanni A, Brimer L. Review scopoletin - A coumarin phytoalexin with medicinal properties. CRC Crit Rev Plant Sci. 2012;31(1):47-56. [CrossRef]
Asif M. Pharmacological activities and phytochemistry of various plant containing coumarin derivatives. Curr Sci Perspect. 2015;1(3):77-90.
Mahadeva Rao US, Mohd KS, Atif AB, Latif AZBA. Scopoletin (coumarin extracted from Mengkudu): Chemical, biological, molecular and pharmacokinetic insights - A review. Res J Pharm Technol. 2013;6(9):978-984.
Pereira dos Santos Nascimento MV, Arruda-Silva F, Gobbo Luz AB, Baratto B, Venzke D, Mendes BG, Fröde TS, Geraldo Pizzolatti M, Dalmarco EM. Inhibition of the NF-κB and p38 MAPK pathways by scopoletin reduce the inflammation caused by carrageenan in the mouse model of pleurisy. Immunopharmacol Immunotoxicol. 2016;38(5):344-352. [CrossRef]
Shi W, Hu J, Bao N, Li D, Chen L, Sun J. Design, synthesis and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole hybrids. Bioorganic Med Chem Lett. 2017;27(2):147-151. [CrossRef]
Malik A, Kushnoor A, Saini V, Singhal S, Kumar S, Yadav YC. In vitro antioxidant properties of Scopoletin. J Chem Pharm Res. 2011;3(3):659-665.
Mogana R, Teng-Jin K, Wiart C. Anti-inflammatory, anticholinesterase, and antioxidant potential of scopoletin isolated from Canarium patentinervium Miq. (Burseraceae Kunth). Evidence-based Complement Altern Med. 2013;2013. [CrossRef]
Shaw CY, Chen CH, Hsu CC, Chen CC, Tsai YC. Antioxidant properties of scopoletin isolated from Sinomonium acutum. Phytother Res. 2003;17(7):823-825. [CrossRef]
Guantai AN, Addae-Mensah I. Cardiovascular effect of Artemisia afra and its constituents. Pharm Biol. 1999;37(5):351356. [CrossRef]
Iizuka T, Nagumo S, Yotsumoto H, Moriyama H, Nagai M. Vasorelaxant effects of Acer nikoense extract and isolated coumarinolignans on rat aortic rings. Biol Pharm Bull. 2007;30(6):1164-1166. [CrossRef]
Wigati D, Anwar K, Sudarsono, Nugroho AE. Hypotensive activity of ethanolic extracts of Morinda citrifolia L. leaves and fruit in dexamethasone-induced hypertensive rat. J Evid Based Complementary Altern Med. 2017;22(1):107-113. [CrossRef]
Akpaffiong MJ, Taylor AA. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens. 1998;11(12):1450-1460. [CrossRef]
Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci. 1997;92(4):361-365.
Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: A Meta-analysis of randomized controlled trials. PLoS One. 2013;8(2):e56803. [CrossRef]
Yanai H, Ito K, Yoshida H, Tada N. Antihypertensive effects of astaxanthin. Integr Blood Press Control. 2008;1(2005):1-3. [CrossRef]
Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev. 2008;60(4):418-469. [CrossRef]
Schulz E, Gori T, Münzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34(6):665-673. [CrossRef]
Badyal DK, Lata H, Dadhich AP. Animal models of hypertension and effect of drugs. Indian J Pharmacol. 2003;35:349362.
Dornas WC, Silva ME. Animal models for the study of arterial hypertension. J Biosci. 2011;36(4):731-737. [CrossRef]
Parasuraman S, Raveendran R. Measurement of invasive blood pressure in rats. J Pharmacol Pharmacother. 2012;3(2):172-177.
Ward M, Langton JA. Blood pressure measurement. Contin Educ Anaesthesia, Crit Care Pain. 2007;7(4):122-126. [CrossRef]
Armenia A, Yuliandra Y, Sattar MZA. Comparative effectiveness of defatted hypotensive crude extract, ethyl acetate and butanolic fractions of Cassytha filiformis L. on different models of hypertensive rats. World J Pharm Pharm Sci. 2014;3(12):200-208.
Yuliandra Y, Armenia A, Arifin H. Antihypertensive and antioxidant activity of Cassytha filiformis L.: A correlative study. Asian Pac J Trop Biomed. 2017;7(7):614-618. [CrossRef]
McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: The role of superoxide anion. Hypertension. 1999;34(4 I):539–545. [CrossRef]
Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000;86(9):960–966. [CrossRef]
Spieker LE, Noll G, Ruschitzka FT, Maier W, Luscher TF. Working under pressure: The vascular endothelium in arterial hypertension. J Hum Hypertens. 2000;14(10–11):617–630. [CrossRef]
Talas ZS, Ozdemir I, Ciftci O, Cakir O, Gulhan MF, Pasaoglu OM. Role of propolis on biochemical parameters in kidney and heart tissues against L-NAME induced oxidative injury in rats. Clin Exp Hypertens. 2014;36(7):492-496. [CrossRef]
Iyer A, Chan V, Brown L. The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and ınflammatory stress. Curr Cardiol Rev 2010;6(4):291–297. [CrossRef]
Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003;41(6):1346–1352. [CrossRef]
Sainz J, Wangensteen R, Gómez IR, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am J Hypertens. 2005;18(6):871-877. [CrossRef]
Cosentino F, Christopher Sill J, Katušić ZS. Role of superoxide anions in the mediation of endothelium-dependent contractions. Hypertension. 1994;23(2):229-235. [CrossRef]
Beigrezaei S, Nasri H. Tempol as an antioxidant; an updated review on current knowledge. Ann Res Antioxidants. 2017;2(1):e01.
Dornas WC, Silva M, Tavares R, De Lima WG, Dos Santos RC, Pedrosa ML, Silva ME. Efficacy of the superoxide dismutase mimetic tempol in animal hypertension models: a meta-analysis. J Hypertens. 2015;33(1):14-23. [CrossRef]
Adaramoye O, Farombi E, Nwosu I. Sub-acute effect of NG-nitro-l-arginine methyl-ester (L-NAME) on biochemical indices ins rats: Protective effects of Kolaviron and extract of Curcuma longa L. Pharmacognosy Res. 2012;4(3):127. [CrossRef]
Alp Yildirim FI, Eker Kizilay D, Ergin B, Balci Ekmekçi O, Topal G, Kucur M, Demirci Tansel C, Uydeş Doʇan BS. Barnidipine ameliorates the vascular and renal injury in l-NAME-induced hypertensive rats. Eur J Pharmacol. 2015;764:433-442. [CrossRef]
Hock FJ, ed. Drug Discovery and Evaluation: Pharmacological Assays. 4th ed. Springer International Publishing; 2015. [CrossRef]
Liu SL, Hsieh MT, Liu CH. Pharmacokinetics of scopoletin after intravenous administration in rabbits. Chinese Pharm J. 1999;51(4):245-254.